Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications
Open accessThe DOI matches its Crossref record; 186 of the 203 references it cites were found in a registry or an index.
Abstract
The tremendous therapeutic potential of voltage-gated sodium channels (Navs) has been the subject of many studies in the past and is of intense interest today. Nav1.7 channels in particular have received much attention recently because of strong genetic validation of their involvement in nociception. Here we summarize the current status of research in the Nav field and present the most relevant recent developments with respect to the molecular structure, general physiology, and pharmacology of distinct Nav channel subtypes. We discuss Nav channel ligands such as small molecules, toxins isolated from animal venoms, and the recently identified Nav1.7-selective antibody. Furthermore, we review eight characterized ligand binding sites on the Nav channel α subunit. Finally, we examine possible therapeutic applications of Nav ligands and provide an update on current clinical studies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sodium channels are pseudo-heterotetrameric protein structures consisting of four highly similar domains, termed I, II, III, and IV (Figure 1). Each domain contains 6 membrane-spanning segments S1-S6 (Figure 1) [4] with S1-S4v forming the voltage-sensing domains and S5-S6 forming the pore loops and DEKA selectivity filter.”
From Progress in Understanding and Treating SCN2A-Mediated Disorders (2018) · cites this paper as [4]
Citations
Cites
1 retracted
Lee, J.-H., Park, C.-K., Chen, G., Han, Q., Xie, R.-G., Liu, T., Ji, R.-R., & Lee, S.-Y. (2014) · Cell · doi:10.1016/j.cell.2014.03.064 · Cited by 207
RetractedHodgkin, A. L., & Huxley, A. F. (1952) · The Journal of Physiology · doi:10.1113/jphysiol.1952.sp004764 · Cited by 23,191
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
The Economic Costs of Pain in the United States
Gaskin, D. J., & Richard, P. (2012) · The Journal of Pain · doi:10.1016/j.jpain.2012.03.009 · Cited by 2,359
Catterall, W. A., Goldin, A. L., & Waxman, S. G. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.4.4 · Cited by 2,254
From Ionic Currents to Molecular Mechanisms
Catterall, W. A. (2000) · Neuron · doi:10.1016/s0896-6273(00)81133-2 · Cited by 2,118
De novo mutations revealed by whole-exome sequencing are strongly associated with autism
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., et al. (2012) · Nature · doi:10.1038/nature10945 · Cited by 2,084
An SCN9A channelopathy causes congenital inability to experience pain
Cox, J. J., Reimann, F., Nicholas, A. K., Thornton, G., Roberts, E., Springell, K., Karbani, G., Jafri, H., Mannan, J., Raashid, Y., et al. (2006) · Nature · doi:10.1038/nature05413 · Cited by 1,600
The crystal structure of a voltage-gated sodium channel
Payandeh, J., Scheuer, T., Zheng, N., & Catterall, W. A. (2011) · Nature · doi:10.1038/nature10238 · Cited by 1,429
The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways
Akopian, A. N., Souslova, V., England, S., Okuse, K., Ogata, N., Ure, J., Smith, A., Kerr, B. J., McMahon, S. B., Boyce, S., et al. (1999) · Nature Neuroscience · doi:10.1038/9195 · Cited by 816
Calcium channel characteristics conferred on the sodium channel by single mutations
Heinemann, S. H., Terlau, H., Stühmer, W., Imoto, K., & Numa, S. (1992) · Nature · doi:10.1038/356441a0 · Cited by 784
Molecular mechanisms of neurotoxin action on voltage-gated sodium channels
Cestèle, S. (2000) · Biochimie · doi:10.1016/s0300-9084(00)01174-3 · Cited by 739
Nassar, M. A., Stirling, L. C., Forlani, G., Baker, M. D., Matthews, E. A., Dickenson, A. H., & Wood, J. N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404915101 · Cited by 681
The NaV1.7 sodium channel: from molecule to man
Dib-Hajj, S. D., Yang, Y., Black, J. A., & Waxman, S. G. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3404 · Cited by 613
Ion Channel Voltage Sensors: Structure, Function, and Pathophysiology
Catterall, W. A. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.021 · Cited by 568
Jarvis, M. F., Honore, P., Shieh, C.-C., Chapman, M., Joshi, S., Zhang, X.-F., Kort, M., Carroll, W., Marron, B., Atkinson, R., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611364104 · Cited by 528
Venoms as a platform for human drugs: translating toxins into therapeutics
King, G. F. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.621940 · Cited by 516
Bierhaus, A., Fleming, T., Stoyanov, S., Leffler, A., Babes, A., Neacsu, C., Sauer, S. K., Eberhardt, M., Schnölzer, M., Lasitschka, F., et al. (2012) · Nature Medicine · doi:10.1038/nm.2750 · Cited by 495
Crystal structure of a voltage-gated sodium channel in two potentially inactivated states
Payandeh, J., Gamal El-Din, T. M., Scheuer, T., Zheng, N., & Catterall, W. A. (2012) · Nature · doi:10.1038/nature11077 · Cited by 483
Crystal structure of an orthologue of the NaChBac voltage-gated sodium channel
Zhang, X., Ren, W., DeCaen, P., Yan, C., Tao, X., Tang, L., Wang, J., Hasegawa, K., Kumasaka, T., He, J., et al. (2012) · Nature · doi:10.1038/nature11054 · Cited by 466
Gain-of-function Na v 1.8 mutations in painful neuropathy
Faber, C. G., Lauria, G., Merkies, I. S. J., Cheng, X., Han, C., Ahn, H.-S., Persson, A.-K., Hoeijmakers, J. G. J., Gerrits, M. M., Pierro, T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216080109 · Cited by 459
The cystine knot motif in toxins and implications for drug design
Craik, D. J., Daly, N. L., & Waine, C. (2001) · Toxicon · doi:10.1016/s0041-0101(00)00160-4 · Cited by 452
Errington, A. C., Stöhr, T., Heers, C., & Lees, G. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.039867 · Cited by 435
Conus Venom Peptide Pharmacology
Lewis, R. J., Dutertre, S., Vetter, I., & Christie, M. J. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005322 · Cited by 424
Conus geographus toxins that discriminate between neuronal and muscle sodium channels.
Cruz, L. J., Gray, W. R., Olivera, B. M., Zeikus, R. D., Kerr, L., Yoshikami, D., & Moczydlowski, E. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39364-x · Cited by 399
Hains, B. C., Klein, J. P., Saab, C. Y., Craner, M. J., Black, J. A., & Waxman, S. G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-26-08881.2003 · Cited by 382
Neurological perspectives on voltage-gated sodium channels
Eijkelkamp, N., Linley, J. E., Baker, M. D., Minett, M. S., Cregg, R., Werdehausen, R., Rugiero, F., & Wood, J. N. (2012) · Brain · doi:10.1093/brain/aws225 · Cited by 359
Painful and painless channelopathies
Bennett, D. L. H., & Woods, C. G. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70024-9 · Cited by 348
A de novo gain-of-function mutation in SCN11A causes loss of pain perception
Leipold, E., Liebmann, L., Korenke, G. C., Heinrich, T., Gießelmann, S., Baets, J., Ebbinghaus, M., Goral, R. O., Stödberg, T., Hennings, J. C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2767 · Cited by 311
Structure of a bacterial voltage-gated sodium channel pore reveals mechanisms of opening and closing
McCusker, E. C., Bagnéris, C., Naylor, C. E., Cole, A. R., D'Avanzo, N., Nichols, C. G., & Wallace, B. A. (2012) · Nature Communications · doi:10.1038/ncomms2077 · Cited by 311
Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews
Kroenke, K., Krebs, E. E., & Bair, M. J. (2009) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2008.12.006 · Cited by 307
Na+ Channel ? Subunits: Overachievers of the Ion Channel Family
Brackenbury, W. J., & Isom, L. L. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00053 · Cited by 303
Gating pore current in an inherited ion channelopathy
Sokolov, S., Scheuer, T., & Catterall, W. A. (2007) · Nature · doi:10.1038/nature05598 · Cited by 300
Loss-of-function mutations in sodium channel Nav1.7 cause anosmia
Weiss, J., Pyrski, M., Jacobi, E., Bufe, B., Willnecker, V., Schick, B., Zizzari, P., Gossage, S. J., Greer, C. A., Leinders-Zufall, T., et al. (2011) · Nature · doi:10.1038/nature09975 · Cited by 294
Gain-of-function mutations in sodium channel NaV1.9 in painful neuropathy
Huang, J., Han, C., Estacion, M., Vasylyev, D., Hoeijmakers, J. G. J., Gerrits, M. M., Tyrrell, L., Lauria, G., Faber, C. G., Dib-Hajj, S. D., et al. (2014) · Brain · doi:10.1093/brain/awu079 · Cited by 288
Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons
Minett, M. S., Nassar, M. A., Clark, A. K., Passmore, G., Dickenson, A. H., Wang, F., Malcangio, M., & Wood, J. N. (2012) · Nature Communications · doi:10.1038/ncomms1795 · Cited by 283
Agnew, W. S., Levinson, S. R., Brabson, J. S., & Raftery, M. A. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.6.2606 · Cited by 272
Mutations in SCN10A Are Responsible for a Large Fraction of Cases of Brugada Syndrome
Hu, D., Barajas-Martínez, H., Pfeiffer, R., Dezi, F., Pfeiffer, J., Buch, T., Betzenhauser, M. J., Belardinelli, L., Kahlig, K. M., Rajamani, S., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.032 · Cited by 245
McCormack, K., Santos, S., Chapman, M. L., Krafte, D. S., Marron, B. E., West, C. W., Krambis, M. J., Antonio, B. M., Zellmer, S. G., Printzenhoff, D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220844110 · Cited by 244
Ciguatoxins and brevetoxins, neurotoxic polyether compounds active on sodium channels
Dechraoui, M.-Y., Naar, J., Pauillac, S., & Legrand, A.-M. (1999) · Toxicon · doi:10.1016/s0041-0101(98)00169-x · Cited by 242
Two Tarantula Peptides Inhibit Activation of Multiple Sodium Channels
Middleton, R. E., Warren, V. A., Kraus, R. L., Hwang, J. C., Liu, C. J., Dai, G., Brochu, R. M., Kohler, M. G., Gao, Y.-D., Garsky, V. M., et al. (2002) · Biochemistry · doi:10.1021/bi026546a · Cited by 237
Self-citationKlint, J. K., Senff, S., Rupasinghe, D. B., Er, S. Y., Herzig, V., Nicholson, G. M., & King, G. F. (2012) · Toxicon · doi:10.1016/j.toxicon.2012.04.337 · Cited by 227
Purification of the saxitoxin receptor of the sodium channel from rat brain.
Hartshorne, R. P., & Catterall, W. A. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.7.4620 · Cited by 223
Humble, S. R., Dalton, A. J., & Li, L. (2015) · European Journal of Pain · doi:10.1002/ejp.567 · Cited by 220
Noncanonical Roles of Voltage-Gated Sodium Channels
Black, J. A., & Waxman, S. G. (2013) · Neuron · doi:10.1016/j.neuron.2013.09.012 · Cited by 209
Structure and function of voltage‐gated sodium channels at atomic resolution
Catterall, W. A. (2014) · Experimental Physiology · doi:10.1113/expphysiol.2013.071969 · Cited by 207
Beneski, D. A., & Catterall, W. A. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.1.639 · Cited by 203
Voltage-gated sodium channels and metastatic disease
Brackenbury, W. J. (2012) · Channels · doi:10.4161/chan.21910 · Cited by 198
Gain-of-Function Mutations in SCN11A Cause Familial Episodic Pain
Zhang, X. Y., Wen, J., Yang, W., Wang, C., Gao, L., Zheng, L. H., Wang, T., Ran, K., Li, Y., Li, X., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.09.016 · Cited by 197
Mechanisms of Disease: sodium channels and neuroprotection in multiple sclerosis—current status
Waxman, S. G. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0735 · Cited by 192
A common genetic variant within SCN10A modulates cardiac SCN5A expression
van den Boogaard, M., Smemo, S., Burnicka-Turek, O., Arnolds, D. E., van de Werken, H. J. G., Klous, P., McKean, D., Muehlschlegel, J. D., Moosmann, J., Toka, O., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73140 · Cited by 191
Sodium Channels, Inherited Epilepsy, and Antiepileptic Drugs
Catterall, W. A. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140232 · Cited by 191
Diversity of Mammalian Voltage‐Gated Sodium Channels
GOLDIN, A. L. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb11272.x · Cited by 186
Yang, M., Kozminski, D. J., Wold, L. A., Modak, R., Calhoun, J. D., Isom, L. L., & Brackenbury, W. J. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2102-9 · Cited by 184
Yang, S., Xiao, Y., Kang, D., Liu, J., Li, Y., Undheim, E. A. B., Klint, J. K., Rong, M., Lai, R., & King, G. F. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306285110 · Cited by 177
Thottumkara, A. P., Parsons, W. H., & Du Bois, J. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201308235 · Cited by 173
Nav2/NaG Channel Is Involved in Control of Salt-Intake Behavior in the CNS
Watanabe, E., Fujikawa, A., Matsunaga, H., Yasoshima, Y., Sako, N., Yamamoto, T., Saegusa, C., & Noda, M. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-20-07743.2000 · Cited by 170
Ulmschneider, M. B., Bagnéris, C., McCusker, E. C., DeCaen, P. G., Delling, M., Clapham, D. E., Ulmschneider, J. P., & Wallace, B. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214667110 · Cited by 169
Hartshorne, R. P., Messner, D. J., Coppersmith, J. C., & Catterall, W. A. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45312-x · Cited by 166
Global Nav1.7 Knockout Mice Recapitulate the Phenotype of Human Congenital Indifference to Pain
Gingras, J., Smith, S., Matson, D. J., Johnson, D., Nye, K., Couture, L., Feric, E., Yin, R., Moyer, B. D., Peterson, M. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105895 · Cited by 164
Orjala, J., Nagle, D. G., Hsu, V. L., & Gerwick, W. H. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00136a031 · Cited by 155
Sodium channelopathies of skeletal muscle result from gain or loss of function
Jurkat‐Rott, K., Holzherr, B. D., Fauler, M., & Lehmann‐Horn, F. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0814-4 · Cited by 154
The Role of Late I Na in Development of Cardiac Arrhythmias
Antzelevitch, C. N., Nesterenko, V. V., Shryock, J. C., Rajamani, S., Song, Y., & Belardinelli, L. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-41588-3_7 · Cited by 150
Voltage-Gated Sodium Channel in Grasshopper Mice Defends Against Bark Scorpion Toxin
Rowe, A. H., Xiao, Y., Rowe, M. P., Cummins, T., & Zakon, H. H. (2013) · Science · doi:10.1126/science.1236451 · Cited by 150
Treatment of Nav1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blocker
Goldberg, Y. P., Price, N., Namdari, R., Cohen, C. J., Lamers, M. H., Winters, C., Price, J., Young, C. E., Verschoof, H., Sherrington, R. P., et al. (2011) · Pain · doi:10.1016/j.pain.2011.09.008 · Cited by 149
A New Family of Conotoxins That Blocks Voltage-gated Sodium Channels
McIntosh, J. M., Hasson, A., Spira, M. E., Gray, W. R., Li, W., Marsh, M., Hillyard, D. R., & Olivera, B. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16796 · Cited by 146
The Molecular Basis of Acid Insensitivity in the African Naked Mole-Rat
Smith, E. S. J., Omerbašić, D., Lechner, S. G., Anirudhan, G., Lapatsina, L. P., & Lewin, G. R. (2011) · Science · doi:10.1126/science.1213760 · Cited by 146
Zhang, M.-M., Green, B. R., Catlin, P., Fiedler, B., Azam, L., Chadwick, A. T., Terlau, H., McArthur, J. R., French, R. J., Gulyas, J., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704616200 · Cited by 146
Wilson, M. J., Yoshikami, D., Azam, L., Gajewiak, J., Olivera, B. M., Bulaj, G. W., & Zhang, M.-M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107027108 · Cited by 146
μ-Conotoxin PIIIA, a New Peptide for Discriminating among Tetrodotoxin-Sensitive Na Channel Subtypes
Shon, K.-J., Olivera, B. M., Watkins, M., Jacobsen, R. B., Gray, W. R., Floresca, C. Z., Cruz, L. J., Hillyard, D. R., Brink, A., Terlau, H., et al. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-12-04473.1998 · Cited by 143
Fraser, S. P., Ozerlat‐Gunduz, I., Brackenbury, W. J., Fitzgerald, E. M., Campbell, T. M., Coombes, R. C., & Djamgoz, M. B. A. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0105 · Cited by 143
Jarecki, B. W., Piekarz, A. D., Jackson, J. O., & Cummins, T. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40801 · Cited by 139
Channelopathy pathogenesis in autism spectrum disorders
Schmunk, G., & Gargus, J. J. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00222 · Cited by 138
Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations
Cox, J. J., Sheynin, J., Shorer, Z., Reimann, F. M., Nicholas, A. K., Zubović, L., Baralle, M., Wraige, E., Manor, E., Levy, J., et al. (2010) · Human Mutation · doi:10.1002/humu.21325 · Cited by 133
Bagnéris, C., DeCaen, P. G., Naylor, C. E., Pryde, D. C., Nobeli, I., Clapham, D. E., & Wallace, B. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406855111 · Cited by 133
Shaya, D., Findeisen, F., Abderemane-Ali, F., Arrigoni, C., Wong, S., Nurva, S., Loussouarn, G., & Minor, D. L. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.10.010 · Cited by 132
Mapping the receptor site for α-scorpion toxins on a Na + channel voltage sensor
Wang, J., Yarov-Yarovoy, V. M., Kahn, R., Gordon, D., Gurevitz, M., Scheuer, T., & Catterall, W. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112320108 · Cited by 130
Dong, X.-W., Goregoaker, S., Engler, H., Zhou, X., Mark, L., Crona, J. H., Terry, R. L., Hunter, J. C., & Priestley, T. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.01.054 · Cited by 127
The molecular mystique of tetrodotoxin
Moczydlowski, E. G. (2012) · Toxicon · doi:10.1016/j.toxicon.2012.11.026 · Cited by 122
Effects of veratridine on sodium currents and fluxes
Ulbricht, W. (1998) · Springer eBooks · doi:10.1007/bfb0000612 · Cited by 116
Rosker, C., Lohberger, B., Hofer, D., Steinecker-Frohnwieser, B., Quasthoff, S., & Schreibmayer, W. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00070.2007 · Cited by 115
Sea anemone toxins affecting voltage-gated sodium channels – molecular and evolutionary features
Moran, Y., Gordon, D., & Gurevitz, M. (2009) · Toxicon · doi:10.1016/j.toxicon.2009.02.028 · Cited by 114
Yotsu‐Yamashita, M., Kim, Y. H., Dudley, S. C., Choudhary, G., Pfahnl, A. E., Oshima, Y., & Daly, J. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400368101 · Cited by 111
Ion conduction and conformational flexibility of a bacterial voltage-gated sodium channel
Boiteux, C., Vorobyov, I. V., & Allen, T. W. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320907111 · Cited by 108
Djamgoz, M. B. A., & Onkal, R. (2012) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/15748928130107 · Cited by 107
Cestèle, S., Schiavon, E., Rusconi, R., Franceschetti, S., & Mantegazza, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309827110 · Cited by 105
Paroxysmal itch caused by gain-of-function Nav1.7 mutation
Devigili, G., Eleopra, R., Pierro, T., Lombardi, R., Rinaldo, S., Lettieri, C., Faber, C. G., Merkies, I. S. J., Waxman, S. G., & Lauria, G. (2014) · Pain · doi:10.1016/j.pain.2014.05.006 · Cited by 98
Berman, F. W., Gerwick, W. H., & Murray, T. F. (1999) · Toxicon · doi:10.1016/s0041-0101(99)00108-7 · Cited by 97
Inhibition of Sodium Channel Gating by Trapping the Domain II Voltage Sensor with Protoxin II
Sokolov, S., Kraus, R. L., Scheuer, T., & Catterall, W. A. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.041046 · Cited by 96
Self-citationA molluskivorous Conus toxin: conserved frameworks in conotoxins
Hillyard, D. R., Olivera, B. M., Woodward, S. R., Corpuz, G. P., Gray, W. R., Ramilo, C. A., & Cruz, L. J. (1989) · Biochemistry · doi:10.1021/bi00427a049 · Cited by 96
Aldo–Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant Cancers
Matsunaga, T., Wada, Y., Endo, S., Soda, M., El-Kabbani, O. A. L., & Hara, A. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00005 · Cited by 94
Shavkunov, A. S., Wildburger, N. C., Nenov, M. N., James, T. F., Buzhdygan, T. P., Panova, N. I., Green, T. A., Veselenak, R. L., Bourne, N., & Laezza, F. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.445924 · Cited by 92
Batrachotoxin. The Active Principle of the Colombian Arrow Poison Frog, Phyllobates bicolor
Daly, J. W., Witkop, B., Bommer, P., & BIEMANN, K. (1965) · Journal of the American Chemical Society · doi:10.1021/ja01079a026 · Cited by 91
Djamgoz, M. B. A., & Onkal, R. (2013) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892811308010066 · Cited by 90
Perkins, J. R., Antunes‐Martins, A., Calvo, M., Grist, J., Rust, W., Schmid, R., Hildebrandt, T., Kohl, M., Orengo, C. A., McMahon, S. B., et al. (2014) · Molecular Pain · doi:10.1186/1744-8069-10-7 · Cited by 89
Maertens, C., Cuypers, E., Amininasab, M., Jalali, A., Vatanpour, H., & Tytgat, J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.022970 · Cited by 88
Gingold, D. B., Strickland, M. J., & Hess, J. J. (2014) · Environmental Health Perspectives · doi:10.1289/ehp.1307196 · Cited by 84
Shaya, D., Kreir, M., Robbins, R. A., Wong, S., Hammon, J., Brüggemann, A., & Minor, D. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106811108 · Cited by 83
Zhang, J. Z., Yarov-Yarovoy, V. M., Scheuer, T., Karbat, I., Cohen, L., Gordon, D., Gurevitz, M., & Catterall, W. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.282509 · Cited by 82
Structure and Sodium Channel Activity of an Excitatory I1-Superfamily Conotoxin,
Buczek, O., Wei, D., Babon, J. J., Yang, X., Fiedler, B., Chen, P., Yoshikami, D., Olivera, B. M., Bulaj, G. W., & Norton, R. S. (2007) · Biochemistry · doi:10.1021/bi700797f · Cited by 80
The phenotype of congenital insensitivity to pain due to the NaV1.9 variant p.L811P
Woods, C. G., Babiker, M. O. E., Horrocks, I. A., Tolmie, J., & Kurth, I. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.166 · Cited by 80
Crystal Structure and Molecular Imaging of the Nav Channel β3 Subunit Indicates a Trimeric Assembly
Namadurai, S., Balasuriya, D., Rajappa, R., Wiemhöfer, M., Stott, K. M., Klingauf, J., Edwardson, J. M., Chirgadze, D. Y., & Jackson, A. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.527994 · Cited by 78
Nelson, M., Millican-Slater, R. A., Forrest, L. C., & Brackenbury, W. J. (2014) · International Journal of Cancer · doi:10.1002/ijc.28890 · Cited by 77
Tetrodotoxin‐resistant voltage‐gated sodium channels Nav1.8 and Nav1.9 are expressed in the retina
O’Brien, B. J., Caldwell, J. H., Ehring, G. R., O’Brien, K. M. B., Luo, S., & Levinson, S. R. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21701 · Cited by 77
Ovarian cancer: Ion channel and aquaporin expression as novel targets of clinical potential
Frede, J., Fraser, S. P., Oskay-Özcelik, G., Hong, Y., Braicu, E. I., Sehouli, J., Gabra, H., & Djamgoz, M. B. A. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.03.016 · Cited by 76
Role of the C-terminal domain in the structure and function of tetrameric sodium channels
Bagnéris, C., DeCaen, P. G., Hall, B. A., Naylor, C. E., Clapham, D. E., Kay, C. W. M., & Wallace, B. A. (2013) · Nature Communications · doi:10.1038/ncomms3465 · Cited by 76
Cheng, X., Dib‐Hajj, S. D., Tyrrell, L., Morsche, R. H. T., Drenth, J. P. H., & Waxman, S. G. (2011) · Brain · doi:10.1093/brain/awr143 · Cited by 74
Rein, K. S., Baden, D. G., & Gawley, R. E. (1994) · The Journal of Organic Chemistry · doi:10.1021/jo00087a027 · Cited by 72
Barbier, J., Lamthanh, H., Gall, F. L., Favreau, P., Benoit, É., Chen, H., Gilles, N., Ilan, N., Heinemann, S. H., Gordon, D., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309576200 · Cited by 70
Tan, Z., Piekarz, A. D., Priest, B. T., Knopp, K. L., Krajewski, J. L., McDermott, J. S., Nisenbaum, E. S., & Cummins, T. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.5011-13.2014 · Cited by 69
Nav1.7 is the Predominant Sodium Channel in Rodent Olfactory Sensory Neurons
Ahn, H., Black, J. A., Zhao, P., Tyrrell, L., Waxman, S. G., & Dib‐Hajj, S. D. (2011) · Molecular Pain · doi:10.1186/1744-8069-7-32 · Cited by 69
Pathophysiological Role of Omega Pore Current in Channelopathies
Jurkat‐Rott, K., Groome, J. R., & Lehmann‐Horn, F. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00112 · Cited by 69
De novo SCN2A splice site mutation in a boy with Autism spectrum disorder
Tavassoli, T., Kolevzon, A., Wang, A. T., Curchack, J. T., Halpern, D. B., Schwartz, L., Soffes, S., Bush, L., Grodberg, D., Cai, G., et al. (2014) · BMC Medical Genetics · doi:10.1186/1471-2350-15-35 · Cited by 67
Differential Phospholipid Binding by Site 3 and Site 4 Toxins
Smith, J. J., Alphy, S., Seibert, A. L., & Blumenthal, K. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412552200 · Cited by 67
Neuropathy‐associated NaV1.7 variant I228M impairs integrity of dorsal root ganglion neuron axons
Persson, A., Liu, S., Faber, C. G., Merkies, I. S. J., Black, J. A., & Waxman, S. G. (2012) · Annals of Neurology · doi:10.1002/ana.23725 · Cited by 65
Lactam-Stabilized Helical Analogues of the Analgesic μ-Conotoxin KIIIA
Khoo, K. K., Wilson, M. J., Smith, B. J., Zhang, M.-M., Gulyas, J., Yoshikami, D., Rivier, J., Bulaj, G. W., & Norton, R. S. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200839a · Cited by 65
Lampert, A., Eberhardt, M. J., & Waxman, S. G. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-41588-3_5 · Cited by 65
Sodium channel selectivity and conduction: Prokaryotes have devised their own molecular strategy
Finol‐Urdaneta, R. K., Wang, Y., Al-Sabi, A., Zhao, C., Noskov, S. Y., & French, R. J. (2014) · The Journal of General Physiology · doi:10.1085/jgp.201311037 · Cited by 62
Zhang, M., Wilson, M. J., Azam, L., Gajewiak, J., Rivier, J., Bulaj, G. W., Olivera, B. M., & Yoshikami, D. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12051 · Cited by 61
Chemical Engineering and Structural and Pharmacological Characterization of the α-Scorpion Toxin OD1
Durek, T., Vetter, I., Wang, C.-I. A., Motin, L. G., Knapp, O., Adams, D. J., Lewis, R. J., & Alewood, P. F. (2013) · ACS Chemical Biology · doi:10.1021/cb400012k · Cited by 61
Fiedler, B., Zhang, M.-M., Buczek, O., Azam, L., Bulaj, G. W., Norton, R. S., Olivera, B. M., & Yoshikami, D. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.03.019 · Cited by 57
Two Alternative Conformations of a Voltage-Gated Sodium Channel
Tsai, C., Tani, K., Irie, K., Hiroaki, Y., Shimomura, T., McMillan, D. G. G., Cook, G. M., Schertler, G. F. X., Fujiyoshi, Y., & Li, X. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.06.036 · Cited by 57
Park, J. H., Carlin, K. P., Wu, G., Ilyin, V. I., Musza, L. L., Blake, P. R., & Kyle, D. J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500687u · Cited by 55
Mechanism of tetrodotoxin block and resistance in sodium channels
Chen, R., & Chung, S. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.115 · Cited by 54
Muroi, Y., Ru, F., Chou, Y., Carr, M. J., Undem, B. J., & Canning, B. J. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00028.2013 · Cited by 54
Blockade of Na+ Channels in Pancreatic α-Cells Has Antidiabetic Effects
Dhalla, A. K., Yang, M., Ning, Y., Kahlig, K. M., Krause, M., Rajamani, S., & Belardinelli, L. (2014) · Diabetes · doi:10.2337/db13-1562 · Cited by 53
Kudo, Y., Finn, J., Fukushima, K., Sakugawa, S., Cho, Y., Konoki, K., & Yotsu‐Yamashita, M. (2014) · Journal of Natural Products · doi:10.1021/np401097n · Cited by 53
Neuroprotective Effects of Rosmarinic Acid on Ciguatoxin in Primary Human Neurons
Braidy, N., Matin, A., Rossi, F., Chinain, M., Laurent, D., & Guillemin, G. J. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9429-9 · Cited by 52
Wang, C., Zhang, H., Jiang, H., Lu, W., Zhao, Z., & Chi, C. (2005) · Toxicon · doi:10.1016/j.toxicon.2005.10.008 · Cited by 52
Liu, Z., Dai, J., Chen, Z., Hu, W., Xiao, Y., & Liang, S. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-2354-x · Cited by 51
Analysis of the selectivity filter of the voltage-gated sodium channel NavRh
Zhang, X., Xia, M., Li, Y., Liu, H., Jiang, X. J., Ren, W., Wu, J., DeCaen, P. G., Feng, Y., Huang, S., et al. (2012) · Cell Research · doi:10.1038/cr.2012.173 · Cited by 51
A channelopathy contributes to cerebellar dysfunction in a model of multiple sclerosis
Shields, S. D., Cheng, X., Gasser, A. S., Saab, C. Y., Tyrrell, L., Eastman, E. M., Iwata, M., Zwinger, P. J., Black, J. A., Dib‐Hajj, S. D., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22665 · Cited by 49
Evolutionarily conserved intracellular gate of voltage-dependent sodium channels
Oelstrom, K., Goldschen-Ohm, M. P., Holmgren, M., & Chanda, B. (2014) · Nature Communications · doi:10.1038/ncomms4420 · Cited by 49
Shu, Q., & Liang, S. (1999) · Journal of Peptide Research · doi:10.1034/j.1399-3011.1999.00039.x · Cited by 48
Therapeutic potential of NaV1.1 activators
Jensen, H. S., Grunnet, M., & Bastlund, J. F. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.12.007 · Cited by 47
Bottein, M. D., Wacksman, J. J., & Ramsdell, J. S. (2006) · Toxicon · doi:10.1016/j.toxicon.2006.07.032 · Cited by 47
NaVβ Subunits Modulate the Inhibition of NaV1.8 by the Analgesic Gating Modifier μO-Conotoxin MrVIB
Wilson, M. J., Zhang, M.-M., Azam, L., Olivera, B. M., Bulaj, G. W., & Yoshikami, D. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.178343 · Cited by 47
A disulfide tether stabilizes the block of sodium channels by the conotoxin μO§-GVIIJ
Gajewiak, J., Azam, L., Imperial, J. S., Walewska, A., Green, B. R., Bandyopadhyay, P. K., Raghuraman, S., Ueberheide, B. M., Bern, M. W., Zhou, H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324189111 · Cited by 44
Pless, S. A., Fisal, E. D., Niciforovic, A. P., Galpin, J. D., Yang, R. Y., Kurata, H. T., & Ahern, C. A. (2014) · The Journal of General Physiology · doi:10.1085/jgp.201311036 · Cited by 44
Inhibitors of voltage-gated Sodium Channel Na v 1.7: Patent Applications Since 2010
Sun, S., Cohen, C. J., & Dehnhardt, C. M. (2014) · Pharmaceutical Patent Analyst · doi:10.4155/ppa.14.39 · Cited by 43
Muroi, Y., & Undem, B. J. (2013) · Lung · doi:10.1007/s00408-013-9533-x · Cited by 42
Channelopathies, painful neuropathy, and diabetes: which way does the causal arrow point?
Hoeijmakers, J. G. J., Faber, C. G., Merkies, I. S. J., & Waxman, S. G. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.06.003 · Cited by 42
Yamaoka, K., Inoue, M., Miyazaki, K., Hirama, M., Kondo, C., Kinoshita, E., Miyoshi, H., & Seyama, I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806481200 · Cited by 40
Analgesic Effects of Huwentoxin-IV on Animal Models of Inflammatory and Neuropathic Pain
Liu, Y., Wu, Z. B., Tang, D., Xun, X., Liu, L., Li, X., Nie, D., Xiang, Y., Yi, J., & Yi, J. (2013) · Protein and Peptide Letters · doi:10.2174/09298665113206660119 · Cited by 40
Xia, M., Liu, H., Li, Y., Yan, N., & Gong, H. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2013.04.035 · Cited by 40
Investigating the size and dynamics of voltage-gated sodium channel fenestrations
Kaczmarski, J. A., & Corry, B. (2014) · Channels · doi:10.4161/chan.28136 · Cited by 39
SHAN, B., Dong, M., Tang, H., Wang, N., Zhang, J., YAN, C., Jiao, X., Zhang, H., & Wang, C. (2014) · Oncology Letters · doi:10.3892/ol.2014.2110 · Cited by 39
McCall, J. R., Jacocks, H. M., Niven, S. C., Poli, M., Baden, D. G., & Bourdelais, A. J. (2014) · Journal of AOAC International · doi:10.5740/jaoacint.sgemccall · Cited by 39
Abbas, N., Gaudioso, C., Bonnet, C., Gabriac, M., Amsalem, M., Lonigro, A., Padilla, F., Crest, M., Martin‐Eauclaire, M., & Delmas, P. (2013) · Pain · doi:10.1016/j.pain.2013.03.037 · Cited by 38
Sun, S., Jia, Q., Zenova, A., Chafeev, M. A., Zhang, Z., Lin, S., Kwan, R., Grimwood, M. E., Chowdhury, S., Young, C., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.08.017 · Cited by 38
Ekberg, J. A. K., Boase, N. A., Rychkov, G. Y., Manning, J. A., Poronnik, P., & Kumar, S. (2013) · Biochemical Journal · doi:10.1042/bj20131275 · Cited by 36
Ciguatera fish poisoning in Hong Kong–A 10-year perspective on the class of ciguatoxins
Wong, C.-K., Hung, P., & Lo, J. Y. C. (2014) · Toxicon · doi:10.1016/j.toxicon.2014.05.006 · Cited by 34
Mechanism of μ-Conotoxin PIIIA Binding to the Voltage-Gated Na+ Channel NaV1.4
Chen, R., Robinson, A., & Chung, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093267 · Cited by 33
Synthesis of 5‐ and 8‐Deoxytetrodotoxin
Satake, Y., Adachi, M., Tokoro, S., Yotsu‐Yamashita, M., Isobe, M., & Nishikawa, T. (2014) · Chemistry - An Asian Journal · doi:10.1002/asia.201402202 · Cited by 32
Li, P., Khan, N., Afaq, F., Ye, C., & Mukhtar, H. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0052-7 · Cited by 31
Zhang, M., Wilson, M. J., Gajewiak, J., Rivier, J., Bulaj, G. W., Olivera, B. M., & Yoshikami, D. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12119 · Cited by 29
Okura, D., Horishita, T., Ueno, S., Yanagihara, N., Sudo, Y., Uezono, Y., & Sata, T. (2014) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000070 · Cited by 28
Deng, M., Luo, X., Jiang, L., Chen, H., Wang, J., He, H., & Liang, S. (2013) · Toxicon · doi:10.1016/j.toxicon.2013.05.015 · Cited by 28
Proton Sensors in the Pore Domain of the Cardiac Voltage-gated Sodium Channel
Jones, D. K., Peters, C. H., Allard, C. R., Claydon, T. W., & Ruben, P. C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.434266 · Cited by 27
Suy, S., Hansen, T. P., Auto, H., Kallakury, B., & Brown, M. L. (2012) · Journal of Clinical & Experimental Oncology · doi:10.4172/2324-9110.1000102 · Cited by 27
Wang, G. K., & Wang, S. (2014) · Molecular Pharmacology · doi:10.1124/mol.113.091173 · Cited by 27
Tsumuraya, T., Fujii, I., & Hirama, M. (2014) · Journal of AOAC International · doi:10.5740/jaoacint.sgetsumuraya · Cited by 27
Lewis, A. H., & Raman, I. M. (2013) · The Journal of General Physiology · doi:10.1085/jgp.201310984 · Cited by 25
Zhang, X., Cao, B., Wang, J., Liu, J., Tung, V. O. V., Lam, P. K. S., Chan, L. L., & Li, Y. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8220-7 · Cited by 25
De novo design and synthesis of a μ-conotoxin KIIIA peptidomimetic
Brady, R. M., Zhang, M., Gable, R. W., Norton, R. S., & Baell, J. B. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.06.086 · Cited by 24
Molecular Architecture of a Sodium Channel S6 Helix
Yang, Y., Estación, M., Dib‐Hajj, S. D., & Waxman, S. G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.462366 · Cited by 23
Poor alkaloid sequestration by arrow poison frogs of the genus Phyllobates from Costa Rica
Mebs, D., Vargas, J., Pogoda, W., Toennes, S. W., & Köhler, G. (2014) · Toxicon · doi:10.1016/j.toxicon.2014.01.006 · Cited by 21
Introduction to Sodium Channels
Peters, C. H., & Ruben, P. C. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-41588-3_1 · Cited by 20
Ruben, P. C. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-41588-3 · Cited by 17
Wang, H., Zhang, F., Li, D., Xu, S., He, J., Yu, H., Li, J., Liu, Z., & Liang, S. (2013) · Toxicon · doi:10.1016/j.toxicon.2013.01.014 · Cited by 17
Farre, C., & Fertig, N. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.942217 · Cited by 16
A purified Palythoa venom fraction delays sodium current inactivation in sympathetic neurons
Lazcano-Pérez, F., Vivas, O., Román-González, S. A., Rodríguez-Bustamante, E., Castro, H., Arenas, I., García, D. E., Sánchez‐Puig, N., & Arreguín‐Espinosa, R. (2014) · Toxicon · doi:10.1016/j.toxicon.2014.02.013 · Cited by 16
Discovery of Batrachotoxin: The Launch of the Frog Alkaloid Program at NIH
Garraffo, H. M., & Spande, T. F. (2009) · Heterocycles · doi:10.3987/rev-08-sr(d)6 · Cited by 16
THE FAILURE OF RESPIRATION IN DEATH BY TETRODOTOXIN POISONING
Cheng, K., Ling, Y., & Wang, J. C. (1968) · Quarterly Journal of Experimental Physiology and Cognate Medical Sciences · doi:10.1113/expphysiol.1968.sp001951 · Cited by 15
Sodium channel blockers: a patent review (2010 – 2014)
Zuliani, V., Rapalli, A., Patel, M. K., & Rivara, M. (2014) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2014.995628 · Cited by 14
Regulation of cough and action potentials by voltage-gated Na channels
Carr, M. J. (2013) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2013.07.001 · Cited by 14
Kudo, Y., & Shibata, S. (1980) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32194-4 · Cited by 11
Niitsu, A., Yamagaki, T., Harada, M., & Tachibana, K. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.03.034 · Cited by 10
Walewska, A., Han, T., Zhang, M.-M., Yoshikami, D., Bulaj, G. W., & Rolka, K. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.04.041 · Cited by 10
Inoue, M. (2014) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.90.56 · Cited by 10
Vilums, M., Overman, J. P., Klaasse, E., Scheel, O., Brussee, J., & IJzerman, A. P. (2011) · ChemMedChem · doi:10.1002/cmdc.201190057 · Cited by 9
Li, T., Xu, L., Liu, H., He, Y., Liang, S., Li, W., & Wu, Y. (2014) · Toxins · doi:10.3390/toxins6030816 · Cited by 8
Goldberg, Y. P., Cohen, C. J., Namdari, R., Price, N., Cadieux, J. A., Young, C., Sherrington, R., & Pimstone, S. N. (2014) · Pain · doi:10.1016/j.pain.2014.01.003 · Cited by 7
Sato, K., Yamaguchi, Y., & Ishida, Y. (2013) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-013-9389-1 · Cited by 6
Zhang, Y., Jia, Y.-Y., Guo, J.-L., Liu, P., & Jiang, J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14059779 · Cited by 5
Re‐engineering the μ‐conotoxin SIIIA scaffold
Akondi, K. B., Lewis, R. J., & Alewood, P. F. (2013) · Biopolymers · doi:10.1002/bip.22368 · Cited by 3
Research works printed but not linked: 6
- Nardi, 2012, Advances in targeting voltage-gated sodium channels with small molecules, ChemMedChem, 7, 1
- Moreau, 2014, Biophysics, pathophysiology, and pharmacology of ion channel gating pores, Front. Pharmacol., 3, 5
- Cestèle, 2013, Nonfunctional Nav1.1 familial hemiplegic migraine mutant transformed into gain of function by partial rescue of folding defects, Proc. Natl. Acad. Sci. U. S. A., 110, 17546, 10.1073/pnas.1309827110 · DOI
- (a) Convergence Pharmaceuticals’ Novel Nav1.7 Selective Sodium Channel Blocker CNV1014802 Demonstrates Proof of Concept in Second Neuropathic Pain Study in Lumbosacral Radiculopathy; Convergence Pharmaceuticals: Cambridge, UK, Sept23, 2014; http://www.convergencepharma.com/userfiles/file/140923_LSR_FINAL.pdf, (accessed Mar 20, 2015).
- (b) The Pipeline; Convergence Pharmaceuticals: Cambridge, UK, 2015; http://www.convergencepharma.com/?page_id=16, (accessed Mar 20, 2015).
- Kwong, 2013, Pharmacological Characterization Of GSK2339345, A Novel Voltage-Gated Sodium Channel Blocker For The Symptomatic Relief Of Cough, Am J. Resp. Crit. Care Med., 187, A4936
Cited by
RCSB Protein Data Bank: Enabling biomedical research and drug discovery
Goodsell, D. S., Zardecki, C., Di Costanzo, L., Duarte, J. M., Hudson, B. P., Persikova, I., Segura, J., Shao, C., Voigt, M., Westbrook, J. D., et al. (2020) · Protein Science · doi:10.1002/pro.3730 · Cited by 353
Progress in Understanding and Treating SCN2A-Mediated Disorders
Sanders, S. J., Campbell, A. J., Cottrell, J. R., Moller, R. S., Wagner, F. F., Auldridge, A. L., Bernier, R. A., Catterall, W. A., Chung, W. K., Empfield, J. R., et al. (2018) · Trends in Neurosciences · doi:10.1016/j.tins.2018.03.011 · Cited by 338
“Each domain containssixmembrane-spanningsegmentsS1–S6 (Figure1) [4]withS1–S4v forming thevoltagesensing domains and S5–S6 forming the pore loops and DEKA-selectivity filter.”
BackgroundStructural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist
Ahuja, S., Mukund, S., Deng, L., Khakh, K., Chang, E., Ho, H., Shriver, S., Young, C., Lin, S., Johnson, J. P., et al. (2015) · Science · doi:10.1126/science.aac5464 · Cited by 319
Angstrom-scale ion channels towards single-ion selectivity
Zhang, H., Li, X., Hou, J., Jiang, L., & Wang, H. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00582k · Cited by 294
Diversity of molecular targets and signaling pathways for CBD
de Almeida, D. L., & Devi, L. A. (2020) · Pharmacology Research & Perspectives · doi:10.1002/prp2.682 · Cited by 257
Metadata
- Authors
- de Lera Ruiz, M., & Kraus, R. L.
- Affiliations
- Merck Research Laboratories , 770 Sumneytown Pike , , ,
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- ORCID
- Kraus, Richard L.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-04-30
- Volume
- 58
- Issue
- 18
- Pages
- 7093-7118
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2031713143
- Cited by
- 548
- References
- 203
- Citations by year
- 2026: 42 · 2025: 58 · 2024: 70 · 2023: 80 · 2022: 71 · 2021: 50 · 2020: 39 · 2019: 37 · 2018: 40 · 2017: 33 · 2016: 20 · 2015: 8
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Medicinal Chemistry (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- voltage-gated sodium channels, Nav1.7, sodium channel structure, sodium channel toxins, ligand binding sites, nociception, pain
- MeSH terms
- Animals, Biological Products, Cardiovascular Diseases, Clinical Trials as Topic, Drug Industry, Epilepsy, Humans, Ligands, Mutation, Neoplasms, Neuromuscular Diseases, Pain, Respiratory Tract Diseases, Ion Channel Gating, Protein Structure, Tertiary, Protein Subunits, Channelopathies, Voltage-Gated Sodium Channels, Voltage-Gated Sodium Channel Blockers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.